Search research articles
Contact Us
Filters
Showing results (111-120 of 126) with videos related to
Page
of 13
Sort By:
Schizophrenia Research
|
March 22, 2003
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design
T H McGlashan, R B Zipursky, D Perkins, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
April 27, 2013
Informing future research priorities into the psychological and social problems faced by cancer survivors: a rapid review and synthesis of the literature
N Jarrett, I Scott, J Addington-Hall, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
April 15, 2011
The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature
S G Brearley, Z Stamataki, J Addington-Hall, et al.
Schizophrenia Research
|
February 27, 2004
Neuropsychological status of subjects at high risk for a first episode of psychosis
K A Hawkins, J Addington, R S E Keefe, et al.
Schizophrenia Research
|
December 20, 2017
The Early Psychosis Screener (EPS): Item development and qualitative validation
B B Brodey, J Addington, M B First, et al.
British Journal of Cancer
|
November 4, 2011
Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review
A Richardson, J Addington-Hall, Z Amir, et al.
Schizophrenia Research
|
March 22, 2003
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample
T J Miller, R B Zipursky, D Perkins, et al.
Schizophrenia Research
|
July 31, 2024
Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts
L Kennedy, B S Ku, J Addington, et al.
Acta Psychiatrica Scandinavica
|
January 10, 2015
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
A M Auther, K S Cadenhead, R E Carrión, et al.
Schizophrenia Research
|
January 24, 2018
The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning
B B Brodey, R R Girgis, O V Favorov, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 126) with videos related to
Sort By:
Page
of 13
Schizophrenia Research
|
March 22, 2003
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design
T H McGlashan, R B Zipursky, D Perkins, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
April 27, 2013
Informing future research priorities into the psychological and social problems faced by cancer survivors: a rapid review and synthesis of the literature
N Jarrett, I Scott, J Addington-Hall, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
April 15, 2011
The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature
S G Brearley, Z Stamataki, J Addington-Hall, et al.
Schizophrenia Research
|
February 27, 2004
Neuropsychological status of subjects at high risk for a first episode of psychosis
K A Hawkins, J Addington, R S E Keefe, et al.
Schizophrenia Research
|
December 20, 2017
The Early Psychosis Screener (EPS): Item development and qualitative validation
B B Brodey, J Addington, M B First, et al.
British Journal of Cancer
|
November 4, 2011
Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review
A Richardson, J Addington-Hall, Z Amir, et al.
Schizophrenia Research
|
March 22, 2003
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample
T J Miller, R B Zipursky, D Perkins, et al.
Schizophrenia Research
|
July 31, 2024
Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts
L Kennedy, B S Ku, J Addington, et al.
Acta Psychiatrica Scandinavica
|
January 10, 2015
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
A M Auther, K S Cadenhead, R E Carrión, et al.
Schizophrenia Research
|
January 24, 2018
The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning
B B Brodey, R R Girgis, O V Favorov, et al.
Page
of 13